Literature DB >> 8293727

Cigarette smoking under stress: the role of coping expectancies among smokers in a clinic-based smoking cessation program.

W G Shadel, R J Mermelstein.   

Abstract

This study examined 2 expectancies to explain smoking under stress: smokers' expectations about their ability to cope with stress while remaining abstinent and their expectations about the stress-ameliorating and coping benefits of smoking under stress. The interaction of the expectancies concurrently predicted smoking urge under stress, which, in turn, predicted subsequent smoking. The interaction of posttreatment expectancies prospectively predicted smoking status 3 months after treatment, although the coping benefits of smoking expectancy effect was reversed. Expectations about coping ability increased and expectations about the coping benefits of smoking decreased as a function of participating in a smoking cessation program. The discrepant concurrent and prospective findings, reasons that coping expectancies are associated with smoking under stress, and treatment implications are discussed.

Mesh:

Year:  1993        PMID: 8293727     DOI: 10.1037//0278-6133.12.6.443

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  16 in total

1.  Cognitive avoidance as a method of coping with a provocative smoking cue: the moderating effect of nicotine dependence.

Authors:  W G Shadel; R Niaura; M G Goldstein; D B Abrams
Journal:  J Behav Med       Date:  2001-04

2.  Smoking outcome expectancies in military veteran smokers with posttraumatic stress disorder.

Authors:  Timothy P Carmody; Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Anne M Joseph; Jean C Beckham; Jessica W Cook
Journal:  Nicotine Tob Res       Date:  2012-01-23       Impact factor: 4.244

3.  Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation.

Authors:  Andrea H Weinberger; Sherry A McKee; Tony P George
Journal:  Nicotine Tob Res       Date:  2010-07-19       Impact factor: 4.244

4.  Correlates of tobacco product reuptake and relapse among youth and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

Authors:  Kathryn C Edwards; Karin A Kasza; Zhiqun Tang; Cassandra A Stanton; Eva Sharma; Michael J Halenar; Kristie A Taylor; Elisabeth A Donaldson; Lynn C Hull; Maansi Bansal-Travers; Jean Limpert; Izabella Zandberg; Lisa D Gardner; Nicolette Borek; Heather L Kimmel; Wilson M Compton; Andrew Hyland
Journal:  Tob Control       Date:  2020-05       Impact factor: 7.552

5.  Perceived racial/ethnic harassment and tobacco use among African American young adults.

Authors:  Gary G Bennett; Kathleen Yaus Wolin; Elwood L Robinson; Sherrye Fowler; Christopher L Edwards
Journal:  Am J Public Health       Date:  2005-02       Impact factor: 9.308

6.  Individual differences in self-concept among smokers attempting to quit: Validation and predictive utility of measures of the smoker self-concept and abstainer self-concept.

Authors:  W G Shadel; R Mermelstein
Journal:  Ann Behav Med       Date:  1996-09

7.  Momentary precipitants connecting stress and smoking lapse during a quit attempt.

Authors:  Christopher Cambron; Aaron K Haslam; Brian R W Baucom; Cho Lam; Christine Vinci; Paul Cinciripini; Liang Li; David W Wetter
Journal:  Health Psychol       Date:  2019-09-26       Impact factor: 4.267

8.  Acculturation and cigarette smoking among African American adults.

Authors:  E A Klonoff; H Landrine
Journal:  J Behav Med       Date:  1996-10

9.  Employee stress levels and the intention to participate in a worksite smoking cessation program.

Authors:  W F Chan; C A Heaney
Journal:  J Behav Med       Date:  1997-08

10.  Yoga as a complementary treatment for smoking cessation: rationale, study design and participant characteristics of the Quitting-in-Balance study.

Authors:  Beth C Bock; Kathleen M Morrow; Bruce M Becker; David M Williams; Geoffrey Tremont; Ronnesia B Gaskins; Ernestine Jennings; Joseph Fava; Bess H Marcus
Journal:  BMC Complement Altern Med       Date:  2010-04-29       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.